Utilization of neoadjuvant chemotherapy in high-risk, node-negative early breast cancer.
Prakash I, Neely NB, Thomas SM, Sammons S, Blitzblau RC, DiLalla GA, Hyslop T, Menendez CS, Plichta JK, Rosenberger LH, Fayanju OM, Hwang ES, Greenup RA.
Prakash I, et al.
Cancer Med. 2022 Feb;11(4):1099-1108. doi: 10.1002/cam4.4517. Epub 2022 Jan 5.
Cancer Med. 2022.
PMID: 34989142
Free PMC article.